SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis

Clinical and Experimental Metastasis

Volumn 30, Issue 7, 2013, Pages 877-890

  Specht, Susan ^a   Isse, Kumiko ^a   Nozaki, Isao ^b   Lunz III, John G ^a   Demetris, Anthony J ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cancer; Epithelial mesenchymal transition; Metastasis; Mucin 1; Small proline rich protein 2A

Indexed keywords

BETA ACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN GP 130; HEAT SHOCK PROTEIN 90; MICRORNA 145; MUCIN 1; PROLINE RICH PROTEIN; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; SMALL PROLINE RICH PROTEIN 2A; STAT3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; DISTANT METASTASIS; DNA SEQUENCE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MESENCHYME CELL; MESENTERY LYMPH NODE; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR INVASION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMANS; MICE; MICE, SCID; MUCIN-1; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 84890434890     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9589-2     Document Type: Article

References (47)

1. Nozaki I, Lunz JG 3rd, Specht S et al (2005) Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 85(1):109-123
2. Demetris AJ, Lunz JG 3rd, Specht S et al (2006) Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 12(22):3512-3522
3. Demetris AJ, Specht S, Nozaki I et al (2008) Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol 48(2):276-288
4. Cabral A, Voskamp P, Cleton-Jansen AM et al (2001) Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem 276(22):19231-19237
5. Vermeij WP, Alia A, Backendorf C (2011) ROS quenching potential of the epidermal cornified cell envelope. J Invest Dermatol 131(7):1435-1441
6. Vermeij WP, Backendorf C (2010) Skin cornification proteins provide global link between ROS detoxification and cell migration during wound healing. PLoS ONE 5(8):e11957
7. Vermeij WP, Florea BI, Isenia S et al (2012) Proteomic identification of in vivo interactors reveals novel function of skin cornification proteins. J Proteome Res. doi: 10.1021/pr300310b
8. Schafer M, Werner S (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9(8):628-638
9. Yao D, Dai C, Peng S (2011) Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 9(12):1608-1620
10. Sano S, Itami S, Takeda K et al (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 18(17):4657-4668
11. Chiarle R, Simmons WJ, Cai H et al (2005) Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 11(6):623-629
12. Darnell JE Jr (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2(10):740-749
13. Lassmann S, Schuster I, Walch A et al (2007) STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. J Clin Pathol 60(2):173-179
14. Masuda M, Suzui M, Yasumatu R et al (2002) Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62(12):3351-3355
15. Niu G, Wright KL, Huang M et al (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13):2000-2008
16. Li L, Shaw PE (2004) A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun 322(3):1005-1011
17. Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5:14
18. auf dem Keller U, Kumin A, Braun S et al (2006) Reactive oxygen species and their detoxification in healing skin wounds. J Investig Dermatol Symp Proc 11(1):106-111
19. Li C, Jackson RM (2002) Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282(2):C227-C241
20. Terui K, Enosawa S, Haga S et al (2004) Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. J Hepatol 41(6):957-965
21. Mizuguchi Y, Specht S, Lunz JG 3rd et al (2012) Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. PLoS One 7(2):e32449
22. Mizuguchi Y, Specht S, Lunz JG 3rd et al (2012) SPRR2a enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity. BMC Mol Biol 13(1):20
23. Kim JC, Yu JH, Cho YK et al (2012) Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer. Breast Cancer Res Treat 133(3):909-916
24. Hippo Y, Yashiro M, Ishii M et al (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61(3):889-895
25. Chen BS, Wang MR, Cai Y et al (2000) Decreased expression of SPRR3 in Chinese human oesophageal cancer. Carcinogenesis 21(12):2147-2150
26. Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24(3):148-154
27. Yokomuro S, Tsuji H, Lunz JG 3rd et al (2000) Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32(1):26-35
28. Han C, Leng J, Demetris AJ et al (2004) Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest. Cancer Res 64(4):1369-1376
29. Walker JA, Kilroy GE, Xing J et al (2003) Human DNA quantitation using Alu element-based polymerase chain reaction. Anal Biochem 315(1):122-128
30. Suh KS, Roh HR, Koh YT et al (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31(1):12-17
31. Giavazzi R, Jessup JM, Campbell DE et al (1986) Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst 77(6):1303-1308
32. Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4(1):45-60
33. Varki A (2007) Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110(6):1723-1729
34. Guaita S, Puig I, Franci C et al (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277(42):39209-39216
35. Andrianifahanana M, Moniaux N, Batra SK (2006) Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 1765(2):189-222
36. Gao J, McConnell MJ, Yu B et al (2009) MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol 35(2):337-345
37. Sachdeva M, Mo YY (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70(1):378-387
38. Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890
39. Barriere G, Tartary M, Rigaud M (2012) Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells. ISRN Oncol 2012:382010
40. Chaffer CL, Brennan JP, Slavin JL et al (2006) Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66(23):11271-11278
41. Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69(18):7135-7139
42. Klerk CP, Smorenburg SM, Otten HM et al (2005) The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 23(10):2130-2135
43. Moggs JG, Tinwell H, Spurway T et al (2004) Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ Health Perspect 112(16):1589-1606
44. Gaemers IC, Vos HL, Volders HH et al (2001) A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J Biol Chem 276(9):6191-6199
45. Horn G, Gaziel A, Wreschner DH et al (2009) ERK and PI3 K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Exp Cell Res 315(8):1490-1504
46. Roy LD, Sahraei M, Subramani DB et al (2011) MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 30(12):1449-1459
47. Bozkaya G, Korhan P, Cokakli M et al (2012) Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Mol Cancer 11(1):64